Patent Yard Sign in
Canadian application, no grantCanada

G protein-coupled receptors

CA 2394749 A1 · Owner: Pharmacia & Upjohn Company · Inventors: Lind, Peter; Wood, Linda Susan; Parodi, Luis A.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides a gene encoding a G protein-coupled receptor termed nGPCR-x; constructs and recombinant host cells incorporating the genes; the nGPCR-x polypeptides encoded by the gene; antibodies to the nGPCR-x polypeptides; and methods of making and using all of the foregoing.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 28, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 28, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 28, 2000
GrantedNo grant recorded
Term endedDecember 28, 2020
Patent numberCA 2394749 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedDec 28, 2000Term endedDec 28, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.